Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.

Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are ...

Newly FDA-approved HIV prevention drug, Yeztugo, offers protection for six months—yet the need for a vaccine remains, say experts. Thursday, June 19th 2025, 6:07 am By: CBS News ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

FDA approves the world’s only twice-a-year shot to prevent HIV by: Associated Press Posted: Jun 18, 2025 / 03:15 PM EDT Updated: Jun 18, 2025 / 03:15 PM EDT ...

200,000 400,000 600,000 800,000 1,000,000 people 2008 2010 2012 2014 2016 2018 2020 2022 Source:Centers for Disease Control and Prevention Graphic: Alex Ford / NBC News ...